Company LigaChem Biosciences Inc.

Equities

A141080

KR7141080002

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for LigaChem Biosciences Inc.

EPS Revisions

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
65,700 ^KRW	-1.20%		-3.95%	+1.08%

04-08	NextCure, Inc. and LigaChem Biosciences, Inc. Present Preclinical Data on B7-H4 Antibody Drug Conjugate At AACR 2024	CI
03-29	Pan Orion Corp. Ltd. completed the acquisition of 4.93% stake in LegoChem Biosciences, Inc. from Kim Yong Ju and Park Se Jin.	CI

LigaChem Biosciences Inc, formerly LegoChem Biosciences Inc, is a Korea-based biotechnology company mainly engaged in development and discovery of new pharmaceuticals based on medical chemistry. The Company principally involves in the development of new drugs, including antibiotics, anticoagulants, anticancer, antiplatelet, anti-inflammatory, as well as antibody-drug-conjugates (ADC), among others. The Company provides technology transfer, joint and contact research and research services. In addition, the Company sells pharmaceutical products.

Number of employees: 135

KRW in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 62.5 %	20,331	60.8 %	21,342	62.5 %	+4.97%
New Drug Research and Development 37.5 %	13,081	39.2 %	12,804	37.5 %	-2.12%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	33,412	100.0 %	34,146	100.0 %	+2.20%

Managers	Title	Age	Since
Yong-Zu Kim CEO	Chief Executive Officer	68	01/05/06
Se-Jin Park DFI	Director of Finance/CFO	62	-
Chang-Sun Lee CTO	Chief Tech/Sci/R&D Officer	58	-
Beop-Pyo Lee BRD	Director/Board Member	59	-
Rak-Gyeong Song BRD	Director/Board Member	66	-
Young-Lag Cho BRD	Director/Board Member	58	-
Doo-Won Park AUD	Comptroller/Controller/Auditor	69	-

Members of the board	Title	Age	Since
Yong-Zu Kim CEO	Chief Executive Officer	68	01/05/06
Se-Jin Park DFI	Director of Finance/CFO	62	-
Young-Lag Cho BRD	Director/Board Member	58	-
Rak-Gyeong Song BRD	Director/Board Member	66	-
Beop-Pyo Lee BRD	Director/Board Member	59	-
Chang-Sun Lee CTO	Chief Tech/Sci/R&D Officer	58	-
Pil-Jae Maeng BRD	Director/Board Member	69	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	301,316	0	0	91.58 %
Stock B	1	36,165,693	33,120,757 ( 91.58 %)	140,000 ( 0.3871 %)

Name	Equities	%	Valuation
ORION CORP. 25.73 %	9,363,283	25.73 %	461 M ₩
National Pension Service of Korea 3.648 %	1,327,239	3.648 %	65 M ₩
Yong-Zu Kim 3.371 %	1,226,428	3.371 %	60 M ₩
Quad Investment Management Co., Ltd. 3.276 %	1,191,976	3.276 %	59 M ₩
Se-Jin Park 0.4989 %	181,528	0.4989 %	9 M ₩
I. G. Investment Management Ltd. 0.0995 %	36,206	0.0995 %	2 M ₩
Yong-geum Kim 0.0825 %	30,000	0.0825 %	1 M ₩
SEI Investments (Europe) Ltd. 0.0560 %	20,371	0.0560 %	1 M ₩
Korea Investment Management Co., Ltd. 0.0120 %	4,382	0.0120 %	215 914 ₩
Mirae Asset Global Investments Co., Ltd. 0.003463 %	1,260	0.003463 %	62 084 ₩

LegoChem Biosciences, Inc.

8-26 Munpyeongseo-ro Daedeok-gu

34302, Daejeon

http://www.legochembio.com

address LigaChem Biosciences Inc.(A141080)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
LIGACHEM BIOSCIENCES INC.	+1.08%	1.73B
VERTEX PHARMACEUTICALS INCORPORATED	+5.33%	111B
REGENERON PHARMACEUTICALS, INC.	+12.11%	106B
BIONTECH SE	-12.56%	22.24B
ARGENX SE	-3.38%	21.25B
GENMAB A/S	-5.66%	18.97B
WUXI APPTEC CO., LTD.	-35.21%	18.52B
BEIGENE, LTD.	-10.86%	16.81B
SAREPTA THERAPEUTICS, INC.	+37.57%	12.54B
LEGEND BIOTECH CORPORATION	-26.24%	8.09B

Bio Therapeutic Drugs